Barclays’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,284
| Closed | -$46K | – | 4196 |
|
|
2023
Q3 | $46K | Buy |
+14,284
| New | +$46K | ﹤0.01% | 3630 |
|
|
2023
Q1 | – | Sell |
-842,145
| Closed | -$1.97M | – | 4293 |
|
|
2022
Q4 | $1.97M | Buy |
+842,145
| New | +$1.97M | ﹤0.01% | 1660 |
|
|
2021
Q3 | – | Sell |
-546
| Closed | -$6K | – | 3948 |
|
|
2021
Q2 | $6K | Buy |
+546
| New | +$6K | ﹤0.01% | 3942 |
|
|
2021
Q1 | – | Sell |
-10,792
| Closed | -$78K | – | 3900 |
|
|
2020
Q4 | $78K | Sell |
10,792
-4,634
| -30% | -$33.5K | ﹤0.01% | 3047 |
|
|
2020
Q3 | $73K | Sell |
15,426
-3,079
| -17% | -$14.6K | ﹤0.01% | 3139 |
|
|
2020
Q2 | $102K | Buy |
+18,505
| New | +$102K | ﹤0.01% | 3112 |
|
|
2020
Q1 | – | Sell |
-9
| Closed | – | – | 3637 |
|
|
2019
Q4 | $0 | Sell |
9
-16,816
| -100% | – | ﹤0.01% | 3847 |
|
|
2019
Q3 | $114K | Sell |
16,825
-9,100
| -35% | -$61.7K | ﹤0.01% | 3329 |
|
|
2019
Q2 | $174K | Buy |
25,925
+25,762
| +15,805% | +$173K | ﹤0.01% | 3282 |
|
|
2019
Q1 | $1K | Sell |
163
-123,254
| -100% | -$756K | ﹤0.01% | 4183 |
|
|
2018
Q4 | $800K | Buy |
+123,417
| New | +$800K | ﹤0.01% | 1961 |
|
|
2018
Q3 | – | Sell |
-44
| Closed | – | – | 4287 |
|
|
2018
Q2 | $0 | Sell |
44
-520
| -92% | – | ﹤0.01% | 4175 |
|
|
2018
Q1 | $2K | Buy |
564
+506
| +872% | +$1.79K | ﹤0.01% | 4083 |
|
|
2017
Q4 | $0 | Sell |
58
-6
| -9% | – | ﹤0.01% | 4059 |
|
|
2017
Q3 | $0 | Sell |
64
-214
| -77% | – | ﹤0.01% | 3999 |
|
|
2017
Q2 | $1K | Buy |
278
+184
| +196% | +$662 | ﹤0.01% | 3739 |
|
|
2017
Q1 | $0 | Buy |
+94
| New | – | ﹤0.01% | 4011 |
|